Navigation Links
Stryker Orthopaedics Enters into Agreement with OrthoSensor for Intelligent Surgical Platform
Date:8/17/2011

MAHWAH, N.J. and SUNRISE, Fla., Aug. 17, 2011 /PRNewswire/ -- Stryker Corporation's Orthopaedics Division and OrthoSensor, Inc., the leader in intelligent orthopaedics, today announced an agreement in which OrthoSensor will provide the OrthoSensor™ Knee Trial, designed for use with Stryker's Triathlon Knee System. The OrthoSensor Knee Trial is an intelligent trial that provides quantitative, intra-operative feedback to surgeons to optimize joint balance during total knee arthroplasty.  

The OrthoSensor Knee Trial has embedded micro-electronics and sensors in single-use trial inserts, delivering data to optimize the final ligament balance and patients' specific joint kinematics.  The sensor wirelessly transmits this key information to a graphic display of real-time feedback, enabling the surgeon to visualize and quantify joint loading and balance.  With this evidence, the surgeon can make an informed choice to modify implant positioning, adjust leg alignment and optimize soft tissue balance through a full range of motion.

"The single radius design philosophy of Stryker knees is a perfect complement to OrthoSensor's innovative technology," said Doug Leach, vice president of global research and development, knee reconstruction at Stryker Orthopaedics. "The Triathlon Knee System is uniquely suited to the finer elements of ligament balancing and being able to take advantage of this new offering provides us with the opportunity to combine our advanced orthopaedic implant technology with cutting-edge sensor technology."

Stryker's Triathlon Knee System offers patients the potential for improved motion(1) and better fit(2), and remains classified as the knee system that outperforms the most frequently used brands in terms of revision rates as identified in the National Joint Registry of England and Wales.(3,4).

"By integrating sensors into the surgical suite, OrthoSensor is leading the evolution in intelligent orthopaedic surgery and we are pleased to collaborate with Stryker Orthopaedics to turn this new field into a reality," said Jay Pierce, CEO of OrthoSensor. "Until now, surgeons have lacked quantifiable data about joint kinematics and their decisions varied based on individual judgment, experience and skill set. OrthoSensor's intelligent surgical systems will provide surgeons, hospitals and health plans access to real-time data to improve patient care, measure clinical outcomes and lower costs related to treating musculoskeletal disease."

About Stryker OrthopaedicsStryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including hip, knee and upper extremity reconstructive devices, bone cement, trauma implants, bone substitutes and spine systems. For more information about Stryker Orthopaedics, visit: http://www.stryker.com/en-us/products/Orthopaedics/index.htm

About StrykerStryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

About OrthoSensor, Inc. OrthoSensor, Inc. (www.orthosensor.com) is an innovative medical device company developing and commercializing intelligent orthopaedic devices that provide real-time data to surgeons and hospitals during and after surgery.  OrthoSensor's intelligent orthopaedic devices utilize advanced sensor and wireless communication technology with the goal of improving healthcare outcomes and reducing the cost of treating musculoskeletal disease. The company's intelligent orthopaedic instrumentation and implants are designed to enhance surgical implantation, as well as enable remote monitoring of implant function and overall musculoskeletal health.

1. Greene, K.A. Range of Motion: Early Results from the Triathlon® Knee System, Stryker Literature Ref # LSA56. 2005.

2. Hitt, K., et al. Anthropometric Measurement of the Human Knee: correlation to the Sizing of Current Knee Arthroplasty Systems, JBJS, Vol. 85-A, supplement 4, 2003.

3. The National Joint Registry of England and Wales. Annual Report 2010. Table 3.11 Based on mean Revision Rates at three years according to brands for knee replacement procedures undertaken between 1st April 2003 and 31st December 2009, which were linked to a HES/PED Wepisode.

4. The National Joint Registry of England and Wales. Annual Report 2009. Table 3.7 Based on mean Revision Rates at three years according to brands for knee replacement procedures undertaken between 1st April 2003 and 30th November 2008, which were linked to a HES/PED Wepisode.Contact:Jeanine GuilfoyleStephanie MarksStryker OrthopaedicsLazar Partners201-831-6277212-843-0211jeanine.guilfoyle@stryker.com

smarks@lazarpartners.com
'/>"/>

SOURCE Stryker Orthopaedics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms
2. Stryker Ends Distribution Agreement With Corin PLC
3. Stryker Announces Exclusive Collaboration With RegenLab
4. Stryker Launches VersiTomic G-Lok™
5. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
6. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
7. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
8. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
9. Stryker Declares a $0.18 Per Share Quarterly Dividend
10. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
11. Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):